NeoChord
The objective of this study is to evaluate the 5-year outcomes of participants with degenerative mitral valve disease treated with the NeoChord Artificial Chordae System, Model DS1000 in a post-market setting.
Mitral Regurgitation
Mitral Valve Disease
Mitral Valve Insufficiency
Mitral Valve Prolapse
Heart Valve Diseases
NeoChord Artificial Chordae Delivery System, Model DS1000
This study is an observational, single-arm, multicenter post-market registry. Both prospective and retrospective enrollment will be allowed. No additional invasive or burdensome examinations outside those routinely required for the standard mitral valve repair procedure will be requested.
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 500 participants |
| Official Title : | The AcChord Study: A Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System |
| Actual Study Start Date : | 2020-02-09 |
| Estimated Primary Completion Date : | 2022-10 |
| Estimated Study Completion Date : | 2027-12 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
University of Bonn
Bonn, Germany,
RECRUITING
CVC Frankfurt
Frankfurt, Germany,
RECRUITING
University of Mainz
Mainz, Germany,
RECRUITING
Hippokration Hospital
Athens, Greece,
RECRUITING
Triemli Hospital
Zurich, Switzerland,